INVO Bioscience Announces Grand Opening of “Positib Fertility, an INVO Center” in Monterrey, Mexico on November 1, 2021

Oct 14, 2021 | Press Releases

Positib Fertility, an INVO Center, becomes first international JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and MONTERREY, Mexico, Oct. 14, 2021 — INVO Bioscience, Inc. (NASDAQ:...

INVO Bioscience Announces $4.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

Oct 1, 2021 | Press Releases

SARASOTA, Fla., Oct. 1, 2021 — INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo culture system (IVC), INVOcell®, today announced that it has entered into definitive agreements with...

INVO Bioscience Advances INVOcell® Commercialization Efforts With Acquisition in Canada

Sep 9, 2021 | Press Releases

Provides platform to leverage the existing INVOcell product registration in Canada and ongoing work with leading embryologist, Ric Ross, to establish INVO Centers and enhance distribution into existing fertility clinicsSARASOTA, Fla., Sept. 9, 2021 — INVO...

INVO Bioscience Announces Official Opening of “Bloom Fertility, an INVO Center” in Atlanta

Sep 7, 2021 | Press Releases

Bloom Fertility, An INVO Center becomes the second JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla. and ATLANTA, Sept. 7, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical...

Dr. Inger Britt Carlsson, Vice President of Global Medical Affairs for INVO Bioscience, to Present at the 11th Annual AFRH Virtual Conference

Sep 3, 2021 | Press Releases

Dr. Carlsson will be speaking on the topic of INVOcell® as an efficient, patient-centric fertility solution for the growing demand in AfricaSARASOTA, Fla., Sept. 3, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on...